Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Emerg Med J. 2018 Aug;35(8):486-491. doi: 10.1136/emermed-2017-207081. Epub 2018 Apr 24.
2.6% of ED syncope patients will suffer cardiac serious adverse events (SAEs) within 30 days of disposition, and outpatient cardiac testing can improve patient safety. The objective is to determine whether outpatient cardiac testing for ED syncope patients is being appropriately ordered after discharge. To this end, we describe the proportion of high-risk and non-high (low and medium)-risk ED syncope patients as per the Canadian Syncope Risk Score (CSRS) who have a SAE after ED discharge, and the proportion referred for outpatient cardiac testing.
Our multicentre prospective cohort study enrolled adult syncope patients between 2010 and 2014 in five academic EDs. We collected patient characteristics, disposition, CSRS predictors, outpatient referrals and testing results (Holter, echocardiography), and 30-day adjudicated SAE (death due to unknown/cardiac cause, myocardial infarction, arrhythmia and structural heart disease). We used descriptive statistics (mean, SD) to report our results.
Of 3584 enrolled patients (mean age 50.9 years, 57.7% women), 800 patients (22.3%) received an outpatient referral. Of these 800 patients, 40.3% of the non-high-risk patients (305/756) and 54.5% of the high-risk patients (24/44) received outpatient cardiac testing. Of all patients who received cardiac testing, five (1.5%; 95% CI 0.6% to 3.5%) suffered outpatient SAE (60.0% arrhythmias). Of all patients who did not receive cardiac testing, four patients (0.9%; 95% CI 0.3% to 2.2%) suffered SAE (all arrhythmias). Of the 20 (45.5%) high-risk patients who did not receive testing, two patients (10.0%; 95% CI 2.8% to 30.1%) suffered arrhythmias outside the hospital, while among the 451 (59.7%) non-high-risk patients, only two (0.4%; 95% CI 0.1% to 1.6%) suffered outpatient arrhythmias.
Outpatient cardiac testing is largely underused, especially among high-risk ED syncope patients. Better guidelines for outpatient cardiac testing are needed, as the practice is highly variable and mismatched with patient risk.
在出院后 30 天内,ED 晕厥患者中有 2.6%将发生心脏严重不良事件 (SAE),而门诊心脏检查可提高患者安全性。目的是确定 ED 晕厥患者出院后是否适当开出门诊心脏检查。为此,我们根据加拿大晕厥风险评分 (CSRS) 描述高风险和非高(低和中)风险 ED 晕厥患者出院后发生 SAE 的比例,以及转介门诊心脏检查的比例。
我们的多中心前瞻性队列研究纳入了 2010 年至 2014 年间五家学术 ED 的成年晕厥患者。我们收集了患者特征、处置、CSRS 预测因素、门诊转介和检查结果(动态心电图、超声心动图)以及 30 天经裁决的 SAE(死因不明/心脏原因、心肌梗死、心律失常和结构性心脏病所致死亡)。我们使用描述性统计(平均值、标准差)报告结果。
在纳入的 3584 名患者中(平均年龄 50.9 岁,57.7%为女性),800 名患者(22.3%)接受了门诊转介。在这 800 名患者中,非高风险患者中有 40.3%(305/756)和高风险患者中有 54.5%(24/44)接受了门诊心脏检查。在所有接受心脏检查的患者中,有 5 名(1.5%;95%CI 0.6%至 3.5%)发生了门诊 SAE(60.0%为心律失常)。在所有未接受心脏检查的患者中,有 4 名(0.9%;95%CI 0.3%至 2.2%)发生了 SAE(均为心律失常)。在未接受检查的 20 名(45.5%)高风险患者中,有 2 名(10.0%;95%CI 2.8%至 30.1%)发生了院外心律失常,而在 451 名(59.7%)非高风险患者中,仅有 2 名(0.4%;95%CI 0.1%至 1.6%)发生了门诊心律失常。
门诊心脏检查的使用率非常低,尤其是在 ED 晕厥的高风险患者中。需要更好的门诊心脏检查指南,因为这种做法差异很大,与患者风险不匹配。